Aims: To determine the distribution of tenascin in normal and pathological bone marrow.
Tenascin is an extracellular matrix protein which was originally isolated from embryonic tissues." It is also present repeats.9 Because of the epidermal growth factor-like repeats, it has been suggested that tenascin has growth promoting properties.'0 Tenascin has been found in the stroma of various tumours, especially malignant ones.57 1`-4 In tumour tissue it is thought to be synthesised by stromal fibroblasts that are induced by cytokines, especially TGF-J3.5 15 16 Synthesis of tenascin has also been reported in embryonic bronchial epithelial cells,'7 in chondroblasts, smooth muscle cells, and in some other mesenchymal cells.'8 Moreover, intracytoplasmic tenascin immunoreactivity has been detected in malignant melanomas"4 and in lung carcinomas. '9 In haematolymphoid tissues the distribution of tenascin has been studied in lymph nodes and in spleen,20 21 but there are no reports on the distribution of tenascin in bone marrow tissue. In splenic tissue tenascin immunoreactivity is closely associated with the reticular fibres.2' Similarly, in reactive and neoplastic lymph node tissue (except for the nodular sclerosing variant of Hodgkin's lymphoma) tenascin was seen as a reticular network, similar to that detected by the reticulin stain. 20 In the nodular sclerosing variant of Hodgkin's lymphoma the entire fibrotic stromal tissue stains strongly for tenascin. 20 In a previous study we introduced a novel monoclonal tenascin antibody (143DB7): this functions in formalin fixed and paraffin wax embedded material. '9 22 The antibody recognises all three isoforms of tenascin. ' .;.,2< :.
-1 by the biotinylated rabbit anti-mouse antibody and ABC (Dakopatts, Glostrup, Denmark). The colour was developed with diaminobenzidine, after which the sections were mounted in an aqueous medium. The sections were counterstained with a light haematoxylin stain. Negative controls consisted of substituting phosphate buffered saline (140 ml NaCl, 0 01M phosphate buffer, pH 7 2) and normal mouse serum for the primary antibody. The staining reaction was evaluated quantitatively as follows: -negative; (+) occasional positive fibres; + weak reactivity, ++ moderate reactivity; and +++ strong reactivity.
Results
The results are summarised in the table.
Tenascin was found in all bone marrow samples with increased fibrosis or increased amount of reticular fibres. The strongest immunoreactivity was observed in the cases rest were with myelofibrosis; in most cases the immunoid fixed in reactivity was very strong (fig 1) , with only )edded in three cases showing moderate or weak staining. Le patients In fibrotic areas the staining was linear; in the )w biopsy more cellular areas it was mainly reticular. The mined.
staining pattern was similar to that obtained by reticulin staining of the same biopsy specimens. Immunoreactivity was also found in the ;ylene and walls of the dilated sinusoids. idogenous
Tenascin immunoreactivity could also be with 03% seen in all samples from acute and chronic inol for 30 lymphatic leukaemias. The reactivity was, e sections however, weaker than in myelofibrosis. The ck, Darm-staining pattern was reticular. Similar immuhe avidin-noreactivity was also seen in the positive cases s used for of myeloid leukaemias.
Inconsistent reticular staining was seen in :o human the hyperplastic bone marrow. Positive staining e primary was observed in cases with myeloid or megad with the karyocytic hyperplasia (fig 2) , while in erythfollowed roid hyperplasia there was no tenascin immunoreactivity. In normal bone marrow staining was mostly negative. In some cases, however, a few positive fibres could be seen. In the bone trabeculae positivity could be seen in the periosteal region and in osteocytes (fig 3) . The walls of the blood vessels also stained positive.
No tenascin could be observed in the aplastic bone marrow 
